Beam Therapeutics BEAM
NASDAQ BEAM
$24.39 -0.06 (-0.25%)
At close: Oct 1, 2026 · 4:00 PM EDT

Beam Therapeutics (BEAM) Net Equity Issued and Repurchased (2019 - 2026)

Updated

Beam Therapeutics (BEAM) posted Net Equity Issued and Repurchased of $7.52 million for Q2 2026, up 673.2% from $973,000 a year earlier and up 271.5% from the prior quarter.

Analysis

Beam Therapeutics (BEAM) Net Equity Issued and Repurchased (2019 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Net Equity Issued and Repurchased at Beam Therapeutics was $11.85 million, up 92.4% year-over-year; for FY2025, it came in at $4.77 million, down 14.8% from FY2024.

  • Annual Net Equity Issued and Repurchased has declined for four consecutive years, with a five-year compound annual growth rate of -52.3% (FY2020 to FY2025).
  • In prior years, Beam Therapeutics' Net Equity Issued and Repurchased was $5.6 million in FY2024 (-83.3%), $33.6 million in FY2023 (-69.0%), $108.26 million in FY2022 (-85.7%) and $757.45 million in FY2021 (+293.5%).
  • The Q2 2026 figure stands as the highest quarterly Net Equity Issued and Repurchased since Q3 2023.
  • On a year-over-year basis, Net Equity Issued and Repurchased increased in three of the last seven quarters, with growth averaging 118.1%.
  • The strongest year-over-year quarter for Net Equity Issued and Repurchased in the past five years was Q2 2026, with growth of 673.2%; the weakest was Q2 2024, with a decline of 99.8%.
  • According to Business Quant data, Net Equity Issued and Repurchased for the three prior quarters was $2.03 million (Q1 2026), $1.89 million (Q4 2025) and $412,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 43.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 6.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 9.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 47.70 Mn
10 Beam Therapeutics 2.52 Bn 2.52 Bn - 7.52 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 7.52 Mn
Mar 31, 2026 2.03 Mn
Dec 31, 2025 1.89 Mn
Sep 30, 2025 412,000.00
Jun 30, 2025 973,000.00
Mar 31, 2025 1.50 Mn
Dec 31, 2024 2.98 Mn
Sep 30, 2024 706,000.00
Jun 30, 2024 240,000.00
Mar 31, 2024 1.68 Mn
Dec 31, 2023 -202.97 Mn
Sep 30, 2023 34.95 Mn
Jun 30, 2023 107.64 Mn
Mar 31, 2023 93.98 Mn
Dec 31, 2022 31.89 Mn
Jun 30, 2022 22.36 Mn
Mar 31, 2022 54.00 Mn
Dec 31, 2021 20.24 Mn
Sep 30, 2021 318.92 Mn
Jun 30, 2021 158.28 Mn
API Access

Beam Therapeutics Net Equity Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=BEAM&period=max&api_key=YOUR_API_KEY